Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Acro Biomedical (ACBM) Net Margin (2017 - 2022)

Acro Biomedical (ACBM) has 6 years of Net Margin data on record, last reported at 1092.97% in Q4 2022.

  • For Q4 2022, Net Margin fell 146491.0% year-over-year to 1092.97%; the TTM value through Sep 2023 reached 3534.45%, down 245106.0%, while the annual FY2022 figure was 2410.24%, 227489.0% down from the prior year.
  • Net Margin reached 1092.97% in Q4 2022 per ACBM's latest filing, up from 1316.18% in the prior quarter.
  • Across five years, Net Margin topped out at 787.82% in Q3 2019 and bottomed at 1316.18% in Q1 2022.
  • Average Net Margin over 5 years is 120.01%, with a median of 4.41% recorded in 2018.
  • Peak YoY movement for Net Margin: soared 78143bps in 2019, then tumbled -146491bps in 2022.
  • A 5-year view of Net Margin shows it stood at 5.54% in 2018, then skyrocketed by 218bps to 6.54% in 2019, then surged by 80bps to 11.79% in 2020, then soared by 3055bps to 371.94% in 2021, then tumbled by -394bps to 1092.97% in 2022.
  • Per Business Quant database, its latest 3 readings for Net Margin were 1092.97% in Q4 2022, 1316.18% in Q1 2022, and 371.94% in Q4 2021.